Core Points - Tongce Medical's stock increased by 5.14% to 44.57 CNY per share, with a trading volume of 454 million CNY and a turnover rate of 2.33%, resulting in a total market capitalization of 19.936 billion CNY [1] Company Overview - Tongce Medical Co., Ltd. is located at 1 Tongce Medical Building, Shuangkoujing Lane, Xixi Road, Xihu District, Hangzhou, established on August 30, 1995, and listed on October 30, 1996 [1] - The company's main business involves medical service investment and dental medical services, with revenue composition as follows: medical services 92.84%, product sales 4.06%, construction engineering 2.72%, and others 0.38% [1] Shareholder Information - Among the top ten circulating shareholders of Tongce Medical, a fund under Southern Fund holds a position. The Southern CSI 500 ETF (510500) reduced its holdings by 106,700 shares in the third quarter, now holding 4.5641 million shares, accounting for 1.02% of circulating shares [2] - The Southern CSI 500 ETF (510500) was established on February 6, 2013, with a latest scale of 140.098 billion CNY. Year-to-date return is 29.93%, ranking 1781 out of 4217 in its category; the one-year return is 19.19%, ranking 2058 out of 3918; and since inception, the return is 146.52% [2] - The fund manager of Southern CSI 500 ETF (510500) is Luo Wenjie, who has a cumulative tenure of 12 years and 206 days, with total fund assets of 170.445 billion CNY. The best fund return during his tenure is 151.42%, while the worst is -47.6% [2]
通策医疗股价涨5.14%,南方基金旗下1只基金位居十大流通股东,持有456.41万股浮盈赚取994.97万元